General Information:

Id: 46 (click here to show other Interactions for entry)
Diseases: Diabetes mellitus, type I - [OMIM]
Rattus norvegicus
BTO:0000991 pancreatic islet
Reference: Manna P et al.(2009) Protective role of arjunolic acid in response to streptozotocin-induced type-I diabetes via the mitochondrial dependent and independent pathways. Toxicology 257: 53-63 [PMID: 19133311]

Interaction Information:

Comment The addition of arjunolic acid (AA) to STZ treated rats could inhibit or reduce the serum glucose accumulation and decreased the serum NO and TNF-alpha levels.
Formal Description
Interaction-ID: 131

drug/chemical compound

Arjunolic acid

decreases_quantity of



in serum; in STZ treated rats
Drugbank entries Show/Hide entries for TNF